Skip to main content

Table 2 Existing PMF treatments (from [28, 34]) in significant connection set

From: QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Drug Comments Cell lines
Anagrelide Significant negative connections found ASC, NPC
Azacitidine Significant negative connections found VCAP, PC3, MCF7
Busulfan No significant negative connections found  
Cytarabine No significant negative connections found HA1E, PC3, A549, MCF7, VCAP
  (indicative negative connections found)  
Danazol Significant negative connections found PHH, ASC
Decitabine No significant negative connections found  
Epoetin-alpha No data in LINCS set  
Everolimus Significant negative connections found A549, ASC, HT29
Hydroxyurea No data in LINCS set  
Interferon alpha No data in LINCS set  
Lenalidomide Significant negative connections found SNUC4, A375, COV644
Melphalan No significant negative connections found HA1E
  (indicative negative connection found)  
Mercaptopurine Significant negative connection found MCF7
Methylprednisolone Significant negative connection found A549
Pomalidomide No data in LINCS set  
Prednisone No significant negative connections found  
Ruxolitinib Significant negative connection found HEPG2
Thalidomide Significant negative connections found TYKNU, PHH, CL34, HCC515
Thioguanine No data in LINCS set